About this episode
Ever wonder where the next big breakthrough in health will come from? Sometimes, the most innovative solutions arise from the most unexpected places. This week’s podcast episode dives into the fascinating world of a neurosurgeon who’s revolutionizing glucose monitoring. Join us as we explore the groundbreaking work of Dr. Casey Halpern, co-founder of SynchNeuro, who is changing cardiometabolic care via the brain.
We discuss:
The unexpected connection between the brain and metabolism: How a neurosurgeon specializing in Parkinson’s disease came across a game-changing approach to glucose monitoring.
A non-invasive CGM for everyone: Learn about SynchNeuro’s innovative behind-the-ear EEG device that could make continuous glucose monitoring accessible and affordable for millions at risk of Type 2 diabetes and heart disease.
From physician to founder: Dr. Halpern shares his inspiring story as a doctorpreneur, leading the double life of a medical career and leading a cutting-edge health tech startup.
The future of cardiometabolic health: We explore how this new technology, combined with the rise of GLP-1 medications, could transform the way we manage and prevent diabetes and heart disease.
The science behind the breakthrough: A deep dive into the research connecting brain signals to appetite and blood sugar regulation.
Tune in to discover how SynchNeuro – a member of our Cardiometabolic Health Moonshot Community – is poised to reshape the landscape of cardiometabolic health and empower individuals to take control of their wellbeing.
For years, chronic health problems like heart disease and Type 2 diabetes have grown, becoming some of society’s biggest killers. Thankfully, there’s a generation of entrepreneurs tackling the issue from every angle. In the Cardiometabolic Health Moonshot Community, mission-aligned founders and CEOs collaborate to accelerate breakthroughs in cardiometabolic disease prevention, diagnosis, monitoring, management, and cures.
» Meet the Community
» Join the Community
